Six Months Intravitreal Ranibizumab Treatment in Neovascular AMD Patients Assessed With Multifocal ERG

被引：0
|
作者：
Pedersen, K. B. [1 ]
Moeller, F. [1 ]
Solie, A. [1 ]
Andreasson, S. [2 ]
机构：
[1] Odense Univ Hosp, Ophthalmol, Odense, Denmark
[2] Lund Univ Hosp, Ophthalmol, Lund, Sweden
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2010年 / 51卷 / 13期
关键词：
age-related macular degeneration; electroretinography: clinical; drug toxicity/drug effects;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2462
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Intravitreal bevacizumab in exudative AMD patients assessed with multifocal ERG and optical coherence tomography
    Pedersen, K. B.
    Sjolie, A. K.
    Moller, F.
    ACTA OPHTHALMOLOGICA, 2008, 86 : 45 - 45
  • [2] Genetic Association with Response to Intravitreal Ranibizumab in Patients with Neovascular AMD
    Kloeckener-Gruissem, Barbara
    Barthelmes, Daniel
    Labs, Stephan
    Schindler, Christian
    Kurz-Levin, Malaika
    Michels, Stephan
    Fleischhauer, Johannes
    Berger, Wolfgang
    Sutter, Florian
    Menghini, Moreno
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (07) : 4694 - 4702
  • [3] Ranibizumab for the treatment of neovascular AMD
    Kaiser, P. K.
    Do, D. V.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (03) : 501 - 509
  • [4] Multifocal ERG and Microperimetry Changes in Response to Ranibizumab Treatment of Neovascular AMD: Randomized Phase 2 Open-Label Study
    Asahi, Masumi G.
    Wallsh, Josh
    Onishi, Spencer M.
    Kuroyama, Shari
    Gallemore, Ron P.
    CLINICAL OPHTHALMOLOGY, 2020, 14 : 3599 - 3610
  • [5] Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD
    Avery, Robert L.
    Castellarin, Alessandro A.
    Steinle, Nathan C.
    Dhoot, Dilsher S.
    Pieramici, Dante Joseph
    See, Robert
    Couvillion, Stephen
    Nasir, Ma'an A.
    Rabena, Melvin D.
    Le, Kha
    Maia, Mauricio
    Visich, Jennifer E.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2014, 98 (12) : 1636 - 1641
  • [6] Intravitreal Aflibercept in Eyes with Neovascular AMD Requiring Frequent Retreatment with Intravitreal Bevacizumab or Ranibizumab
    Thorell, Mariana Rossi
    Nunes, Renata Portella
    Gregori, Giovanni
    Feuer, William J.
    Rosenfeld, Philip J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [7] Intravitreal ranibizumab as adjuvant treatment for neovascular glaucoma
    Ticly, Flavia Gazze
    Cavalcanti Lira, Rodrigo Pessoa
    Medeiros Fulco, Enzo Augusto
    Cabral de Vasconcelos, Jose Paulo
    REVISTA BRASILEIRA DE OFTALMOLOGIA, 2013, 72 (02) : 119 - 121
  • [8] Intravitreal Injections of Ranibizumab (Lucentis) for Treatment of Wet AMD
    Smirnov, E.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [9] Multifocal electroretinography in patients with exudative AMD and intravitreal treatment with pegaptanib sodium
    Lipski, Andreas
    Bornfeld, Norbert
    Jurklies, Bernhard
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (07): : 864 - 872
  • [10] Evaluating the Effect of Intravitreal Ranibizumab on Retrobulbar Hemodynamics by Color Doppler Ultrasonography in Neovascular AMD
    Raza, Sabri
    Ergun, Sule Berk
    Toklu, Yasin
    Cakmak, Hasan Basri
    Ipek, Ali
    Cagil, Nurullah
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2019, 50 (07): : 437 - 443
12345